Industri

SSM Health to Top Out New Cardinal Glennon Children’s H...

SSM Health will celebrate a major construction milestone on its new Cardinal Gle...

Agilent expands India’s scientific ecosystem with new c...

Agilent Technologies has announced the opening of its Customer Experience Cente...

Glenmark to manage end-to-end commercialisation and dis...

RYALTRIS is Glenmark’s first innovative product introduced into the US market T...

Lupin completes acquisition of VISUfarma

The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to ov...

Merck KGaA acquires JSR chromatography business

This follows the company’s signing of a definitive agreement in October 2025 to ...

Biocytogen and Sihuan partner to advance new therapeuti...

Under the agreement, Biocytogen’s fully human antibody discovery platform will b...

Telomir seeks FDA approval for Telomir-1 to treat breas...

The IND includes results from completed toxicology, pharmacology, and manufactur...

Why Parking Structures Matter in Healthcare Design

Healthcare organizations often focus on designing welcoming lobbies and patient-...

Symeres and Ambagon collaborate for colorectal cancer m...

The partnership aims to explore a new class of small molecules, called molecular...

Enthral.ai partners with Alembic Pharmaceuticals to dep...

Platform to support compliance, training and documentation for over 9,000 lear...

Express Pharma April 2026

India's Foremost Pharma & Biotech Magazine ~ Patent Expiries Ahead: Is India Ph...

Midst global headwinds, CDSCO cracks down on GLP-1 gold...

As pharma companies deal with price wars, increasing regulatory heat and a vola...

Eli Lilly to acquire Centessa Pharmaceuticals under def...

Acquisition to include orexin receptor portfolio for sleep and neurological co...

Harris County, Texas, OKs Eminent Domain Step for Ben T...

Harris County, Texas, Commissioners have authorized the use of eminent domain to...

Teva receives FDA approval for Prolia biosimilar

The FDA approval of Ponlimsi is based on a comprehensive evidence package, inclu...

uBriGene and Cellinfinity BIO collaborate to accelerate...

The partnership focuses on progressing Cellinfinity BIO’s programmes CIB-301 and...